Jason Gardner, Magenta Therapeutics CEO
April 14, 2022 11:12 AM EDT
People
R&D

Ma­gen­ta feels the biotech blues, an­nounces lay­offs and clin­i­cal tri­al cuts

Lei Lei Wu

News Reporter

Ma­gen­ta Ther­a­peu­tics is fol­low­ing the flood of biotech lay­offs, an­nounc­ing to­day that it is cut­ting its work­force by 14% be­fore da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lex­i­con ends com­mer­cial work to fo­cus on R&D

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times